Complete Case – Dr Chang – Video – Phase 1

COMPLETE CASE
 
Biomarker Testing in Advanced NSCLC: A Pathology Perspective

Chung-Che (Jeff) Chang, MD, PhD Medical Director, Hematology and Molecular Pathology Labs, Florida Hospital Cancer Institute, Orlando, Florida

Dr. Chang discusses how to improve biomarker testing success rates in NSCLC through optimizing sample selection and instituting protocols that reduce front-end turnaround time
 
CASE STUDY ON BIOMARKER TESTING IN ADVANCED NSCLC

Case Study Patient Case: Biomarker Testing in Advanced NSCLC


Chung-Che (Jeff) Chang, MD, PhD A Case-Based Pathology Perspective on Biomarker Testing in NSCLC


Gaetane C. Michaud, MD A Case-Based Pulmonology Perspective on Biomarker Testing in NSCLC


Mark A. Socinski, MD A Case-Based Oncology Perspective on Biomarker Testing in NSCLC

 
EXPERTS’ INSIGHTS ON BIOMARKER TESTING IN ADVANCED NSCLC

Chung-Chee (Jeff) Chang, MD, PhD A Pathology Perspective on Biomarker Testing in NSCLC


Martin Dietrich, MD, PhD A Community Oncology Perspective on Biomarker Testing in NSCLC


Gaetane C. Michaud, MD A Pulmonology Perspective on Biomarker Testing in NSCLC


Mark A. Socinski, MD An Oncology Perspective on Biomarker Testing in NSCLC

Webcasts